The entrepreneur says biotech should be less contentious than AI, as a breakthrough in Beijing is just as usable in Boston.

Epidermolysis bullosa is a rare and severe skin disease where patients have fragile skin that blisters and tears. A Mt.

French pharmaceutical and healthcare company Sanofi said on Monday it will buy US-based Blueprint Medicines. The transaction ...

Janice Chen co-founded Mammoth Biosciences after inventing a powerful gene detection tool in grad school. Now she's helping ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

There are a range of engaging and educational summer camp opportunities being offered at California State University, ...

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

Mount Marty University will launch the region’s first Graduate Regulatory Science Program to train future leaders in the ...

In the dynamic world of life sciences, companies face unique challenges in safeguarding their valuable assets. From ...

Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

A US-based biotech company has successfully sequenced the genetic codes of preserved plants, some of which date back more ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he may no longer allow government ...